News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Catalent Completes Expansion of Clinical Supply Facility Worth $25 Million in Schorndorf, Germany
Tuesday, July 16, 2024Catalent Inc has recently completed the expansion of its clinical supply facility located in Schorndorf Germany This expansion marks a significant upgrade to Catalents flagship European site adding square
Sumitomo Pharma Receives FDA Fast Track Designation for DSP-5336 in Relapsed or Refractory Acute Myeloid Leukemia Treatment
Monday, July 15, 2024Sumitomo Pharma America Inc has announced that the US Food and Drug Administration granted Fast Track designation to DSP for the treatment of patients with relapsed or refractory
Arrivo Secures FDA Fast Track Status for RABI-767 Targeting Acute Pancreatitis Patients Likely to Develop Severe Disease
Monday, July 15, 2024Arrivo BioVentures announced today that its subsidiary Panafina Inc has been granted Fast Track Designation by the FDA for RABI an investigational new drug intended for patients
Pan Cancer T Secures €4.25 Million to Advance Next-Generation T Cell Therapies in Seed Extension Round
Friday, July 12, 2024Pan Cancer T BV a biotech startup focusing on advancing T cell therapies for solid cancers has successfully closed a million Seed Extension round This funding includes
Skyhawk Therapeutics Reports Positive Results for SKY-0515 in Huntington's Disease Phase I Trial, Demonstrating Up to 72% Reduction in Huntingtin Protein mRNA
Friday, July 12, 2024Skyhawk Therapeutics Inc has announced positive results from Parts A and B of its Phase clinical trial
AusperBio's AHB-137 Receives Breakthrough Therapy Designation for Chronic Hepatitis B Treatment
Thursday, July 11, 2024AusperBio Therapeutics Inc and Ausper Biopharma Co Ltd have announced that their investigational drug AHB has received Breakthrough Therapy Designation
XyloCor and SmartCella Collaborate on License Agreement for Extroducer in Novel Gene Therapy XC001 Targeting Heart Treatment
Thursday, July 11, 2024XyloCor Therapeutics Inc a company advancing gene therapies for cardiovascular diseases has partnered with SmartWise a unit of SmartCella Holding AB to license the Extroducer Infusion Catheter
Curium Submits NDA for Lutetium Lu 177 Dotatate Injection
Wednesday, July 10, 2024Curium a leader in nuclear medicine announced today the submission of a b New Drug Application for Lutetium Lu Dotatate Injection This application seeks FDA approval for treating somatostatin receptorpositive gastroenteropancreatic neuroendocrine tu...
Abata Therapeutics Gets FDA Approval to Start Clinical Trials of ABA-101 for Progressive Multiple Sclerosis
Tuesday, July 09, 2024Abata Therapeutics has received clearance from the US Food and Drug Administration for its Investigational New Drug application to conduct a Phase study of ABA in patients
RS BioTherapeutics and University of Colorado School of Medicine Announce Research Collaboration
Monday, July 08, 2024RS BioTherapeutics has entered into a collaboration with the University of Colorado School of Medicine to evaluate their novel steroidfree therapeutic platform RSBT for treating lethal lung diseases
